SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lee, T.-M.
Right arrow Articles by Lee, Y.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, T.-M.
Right arrow Articles by Lee, Y.-T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Percutaneous Transvenous Mitral Balloon Valvuloplasty Alone in Patients with Combined Aortic and Mitral Stenosis

Tsung-Ming Lee, MD

Sheng-Fang Su, PhD

Ming-Fong Chen, MD

Chiau-Suong Liau, MD, FACA

Yuan-Teh Lee, MD

To investigate the feasibility of percutaneous transvenous balloon dilatation of the mitral valve in patients with combined aortic and mitral stenosis, 12 patients were studied by echocardiography and catheterization before and after mitral valvuloplasty. Aortic stenosis was defined from prevalvuloplasty catheterization study as a transaortic pressure gradient of more than 25 mm Hg. All 12 patients underwent transvenous balloon mitral valvuloplasty successfully. Immediately after the procedure, all patients experienced improvement in clinical symptoms and in hemodynamic variables. Mitral valve areas were significantly increased from 0.78 ±0.18 to 1.73 ±0.21 cm2 (P<0.0001) by planimetry method. Cardiac output was significantly increased from 3.6 ±0.1 to 4.2 ±0.5 L/min (P=0.01). Mean transaortic flow rate increased 33% (from 198 ±68 to 254 ±41 mL/s, P=0.002). Mean pressure gradient across the aortic valve after mitral valvulo plasty was not significantly increased, from 34 ±7 to 37 ±13 mm Hg. Aortic valve areas, derived from the Gorlin formula, were significantly increased from 0.57 ±0.12 to 0.73 ±0.14 cm2 (P=0.006) after mitral valvuloplasty. However, continuity equation-derived aortic valve area was independent of increasing flow rate after mitral valvuloplasty from 1.29 ±0.35 to 1.30 ±0.29 cm2. During follow-up with a mean of twenty four ±fourteen months, 8 patients were in New York Heart association functional class I, 3 in class II, and 1 in class IV who received pericardiotomy owing to constrictive pericarditis without aortic valve replacement. In conclusion, mitral valvuloplasty alone may be safe and effective in alleviating symptoms in mitral stenosis patients with transaortic pressure gradient >25 mm Hg. Continuity equation-derived aortic valve areas seem to be flow independent in evaluation of aortic stenosis and are important for decision making.

Angiology, Vol. 48, No. 5, 445-450 (1997)
DOI: 10.1177/000331979704800508


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement